Pricing Log in Create free account
Friday 6 November 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.

Revenue
+38.6%
EPS
+16.3%
Free cash flow
+21.8%
Total debt
+15.0%

Quarter to September 2026, against a year earlier

1,363.76 0.97 −0.07%
Market cap
$1.28T
P/E
44.5×
Fwd P/E
41.5×
Dividend yield
0.49%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Eli Lilly and Company (LLY) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Eli Lilly and Company (LLY) trades at a EV/Sales of 14.7×. Over the past ten years it has ranged from 3.6× (December 2016) to 23.5× (June 2024); the current reading is higher than 82% of that period. That is above the Drug Manufacturers General industry median of 4.1× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 15.3× (4.28%)
FY2024 16.0× (0.73%)
FY2023 16.1× 34.24%
FY2022 12.0× 29.21%
FY2021 9.3× 37.42%
FY2020 6.8× 11.64%
FY2019 6.1× 7.98%
FY2018 5.6× 23.28%
FY2017 4.6× 18.94%
FY2016 3.8× (17.80%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 12.5× (10.76%)
Jun 2026 14.0× 17.93%
Mar 2026 11.9× (22.52%)
Dec 2025 15.3× 26.38%
43 more quarters

Against its own ten years

Low 3.6× High 23.5×
Ten-year median 7.0×
Current reading's percentile 80

EV/Sales against peers

Company EV/Sales
PFE Pfizer Inc. compare 3.4×
AZN AstraZeneca PLC compare 5.0×
NVS Novartis AG compare 6.0×
MRK Merck & Co., Inc. compare 6.0×
JNJ Johnson & Johnson compare 6.8×
GILD Gilead Sciences, Inc. compare 7.4×
AMGN Amgen Inc. compare 7.5×
ABBV AbbVie Inc. compare 8.8×
LLY Eli Lilly and Company 14.7×
Drug Manufacturers General industry median 4.1×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on LLY